Menu
Six drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025.

Six Drugmakers to Refund 340B Covered Entities for Overcharges

Shannon Young, Associate Editor/Senior Writer 340B Report Views
Several drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2019 and 2025, following recalculations of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

Stephanie Blaskoski, Regional Manager, SunRx

Health System, Insurer Appear to Settle Lawsuit Alleging Medicare Advantage 340B Underpayments

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live